Thursday, 8 November 2018

Satellite Symposium Sanofi-Genzyme and Regeneron

Type 2 Inflammation in Severe Asthma: Clinical and Therapeutic Implications

18:15 – 19:15
Room: Zaragoza I & II
Chair: Santiago Quirce, Spain
• Welcome and Introductions. Santiago Quirce, Spain
• Defining Severe Asthma. Zuzana Diamant, The Netherlands
• Type 2 Asthma: What Is it and What Mediators Drive It? Santiago Quirce, Spain
• Interactive Session: Identifying Type 2 Asthma in Clinical Practice. G. Walter Canonica, Italy
• Closing Remarks and Panel Q&A. Santiago Quirce, Spain

Friday, 9 November 2018

Satellite Symposium Novartis

New approaches in severe allergic asthma

13:15 – 14:15
Room: Zaragoza I & II
Chair: Ignacio Dávila, Spain
• Defining the severe allergic asthma patient candidate to biologics. Santiago Quirce, Spain
• Component resolved diagnosis in severe allergic asthma. Olga Luengo, Spain

Satellite Symposium ALK

Relevant outcomes in allergic asthma

18:00 – 19:00
Room: Zaragoza I & II
Chair: Eike Wüstenberg, Germany
• Early identification of asthma deterioration for modifying or preventing severe exacerbations. A clinical trial perspective. Göran Eriksson, Sweden
• Can we influence the natural course of asthma in routine care? Eike Wüstenberg, Germany